The Impact of DNA Repair Pathway Alterations Identified by Circulating Tumor DNA on Sensitivity to Radium-223 in Bone Metastatic Castration-Resistant Prostate Cancer
Latest Information Update: 21 Aug 2026
At a glance
- Drugs Radium 223 chloride (Primary)
- Indications Bone metastases; Prostate cancer
- Focus Therapeutic Use
Most Recent Events
- 12 Aug 2026 Planned End Date changed from 1 Aug 2029 to 1 Aug 2030.
- 12 Aug 2026 Planned primary completion date changed from 1 Aug 2026 to 1 Aug 2027.
- 27 Feb 2025 Planned End Date changed from 1 Aug 2028 to 1 Aug 2029.